Stay updated on Oral Elsubrutinib and Upadacitinib in Lupus Clinical Trial
Sign up to get notified when there's something new on the Oral Elsubrutinib and Upadacitinib in Lupus Clinical Trial page.

Latest updates to the Oral Elsubrutinib and Upadacitinib in Lupus Clinical Trial page
- Check2 days agoChange DetectedThe latest version in the study record history indicates the recruitment status is not accepting participants, i.e., not currently recruiting, and is tagged as Revision: v3.6.0. The previous revision tag v3.5.5 has been removed.SummaryDifference0.3%

- Check9 days agoChange DetectedThe history now shows a new revision entry (v3.5.5) added to the history and the previous revision (v3.5.4) removed, updating the page's version history.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check31 days agoChange DetectedA new site revision entry, v3.5.4, was added to the history. This reflects a platform update rather than an alteration to the study record content.SummaryDifference0.1%

- Check52 days agoChange DetectedThe page’s revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a platform/release change rather than any edit to the study history details.SummaryDifference0.1%

- Check59 days agoChange DetectedRevision: v3.5.2 was added and Revision: v3.5.0 was removed.SummaryDifference0.1%

- Check88 days agoChange DetectedA new Revision: v3.5.0 was added and an existing Revision: v3.4.3 was removed from the study's record history.SummaryDifference0.1%

Stay in the know with updates to Oral Elsubrutinib and Upadacitinib in Lupus Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral Elsubrutinib and Upadacitinib in Lupus Clinical Trial page.